Healthcare-associated infections during the coronavirus disease 2019 (COVID-19) pandemic and the modulating effect of centralized surveillance

Graham M Snyder; Suzanne Wagester; Patricia L Harris; Abby L Valek; Jacob C Hodges; Andrew L Bilderback; Fazrina Kader; Colleen A Tanner; Amy P Metzger; Susan E DiNucci; Bonnie V Colaianne; Ashley Chung; Rachel L Zapf; Paula L Kip; Tamra E Minnier

doi:10.1017/ash.2023.139

Healthcare-associated infections during the coronavirus disease 2019 (COVID-19) pandemic and the modulating effect of centralized surveillance

Antimicrob Steward Healthc Epidemiol. 2023 Apr 11;3(1):e72. doi: 10.1017/ash.2023.139. eCollection 2023.

Authors

Affiliations

¹ Department of Infection Prevention and Control, UPMC Presbyterian/Shadyside, Pittsburgh, Pennsylvania.
² Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
³ Wolff Center, UPMC, Pittsburgh, Pennsylvania.
⁴ Quality and Risk Management, UPMC Passavant, McCandless, Pennsylvania.

Abstract

We analyzed efficacy of a centralized surveillance infection prevention (CSIP) program in a healthcare system on healthcare-associated infection (HAI) rates amid the coronavirus disease 2019 (COVID-19) pandemic. HAI rates were variable in CSIP and non-CSIP facilities. Central-line-associated bloodstream infection (CLABSI), C. difficile infection (CSI), and surgical-site infection (SSI) rates were negatively correlated with COVID-19 intensity in CSIP facilities.